Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-12-002448
Filing Date
2012-03-16
Accepted
2012-03-16 16:56:27
Documents
12
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K athero_10k-123111.htm 10-K 1276090
2 EXHIBIT 23.1 ex23-1.htm EX-23.1 3423
3 EXHIBIT 31.1 ex31-1.htm EX-31.1 16019
4 EXHIBIT 31.2 ex31-2.htm EX-31.2 16180
5 EXHIBIT 32.1 ex32-1.htm EX-32.1 6640
6 EXHIBIT 32.2 ex32-2.htm EX-32.2 6442
  Complete submission text file 0001437749-12-002448.txt   3734892

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE ahro-20111231.xml EX-101.INS 512362
8 XBRL TAXONOMY EXTENSION SCHEMA ahro-20111231.xsd EX-101.SCH 16015
9 XBRL TAXONOMY EXTENSION CALCULATION ahro-20111231_cal.xml EX-101.CAL 18999
10 XBRL TAXONOMY EXTENSION DEFINITION ahro-20111231_def.xml EX-101.DEF 84629
11 XBRL TAXONOMY EXTENSION LABELS ahro-20111231_lab.xml EX-101.LAB 121721
12 XBRL TAXONOMY EXTENSION PRESENTATION ahro-20111231_pre.xml EX-101.PRE 96572
Mailing Address 2301 DUPONT DRIVE, SUITE 525 IRVINE CA 92612
Business Address 2301 DUPONT DRIVE, SUITE 525 IRVINE CA 92612 (949) 525-5471
AtheroNova Inc. (Filer) CIK: 0001377053 (see all company filings)

EIN.: 201915083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52315 | Film No.: 12698313
SIC: 2834 Pharmaceutical Preparations